[1] |
LAN Yu, WANG Fenghua.
Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
[J]. China Oncology, 2025, 35(2): 219-227.
|
[2] |
CAI Shuyue, XIE Quan, ZHOU Yuxuan, LIU Qingzhu, QIU Ling, LIN Jianguo.
Latest progress and prospect of NRP-1 targeted molecular probes for breast cancer diagnosis
[J]. China Oncology, 2025, 35(2): 249-254.
|
[3] |
ZHAO Yihan, LI Ruochen, LIN Yansong.
Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer
[J]. China Oncology, 2025, 35(1): 12-20.
|
[4] |
WANG Renfei, LU Gaixia.
The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2025, 35(1): 49-57.
|
[5] |
Society of Neuroendocrine Neoplasm of China Anti-Cancer Association.
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)
[J]. China Oncology, 2025, 35(1): 85-142.
|
[6] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[7] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[8] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[9] |
Expert Committee on Pathology of Chinese Research Hospital Association , Professional Committee on Tumor Pathology of Shanghai Anticancer Association .
Practice guideline for the histopathological diagnosis of mesothelioma (2025 version)
[J]. China Oncology, 2024, 34(12): 1144-1163.
|
[10] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|
[11] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
[12] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[13] |
XU Hongtao, HUANG Xiaojuan, ZHENG Chongyang, ZHANG Zhiyuan.
Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer
[J]. China Oncology, 2023, 33(9): 874-878.
|
[14] |
JU Shenaonan, WANG Yingying, TANG Yong, YAO Yiyun, WU Yingli, ZHU Qi.
Experimental study on sinomenine derivative modulating chemokine receptor in multiple myeloma cells
[J]. China Oncology, 2023, 33(6): 589-596.
|
[15] |
CHEN Luyan, WANG Lixue, FU Peifen.
The value of surgery in the patients with de novo stage Ⅳ breast cancer
[J]. China Oncology, 2023, 33(5): 431-436.
|